Double-Digit Revenue Growth Driven by Strategic Initiatives Across Industrial and Advanced Solutions
Focused on Driving Margin Expansion
MARLBOROUGH, Mass., Nov. 03, 2026 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (NASDAQ: IPGP) today reported financial results for the third quarter ended September 30, 2026.
| Tres meses terminados el 30 de septiembre, | Nueve meses finalizados el 30 de septiembre, | |||||||||||||||||||||
| (En millones, excepto datos por acción y porcentajes) | 2026 | 2025 | Cambia | 2026 | 2025 | Cambia | ||||||||||||||||
| Ingresos | $ | 287.5 | $ | 250.8 | 15 | % | $ | 831.6 | $ | 729.3 | 14 | % | ||||||||||
| Margen bruto | 40.7 | % | 39.5 | % | 39.6 | % | 38.7 | % | ||||||||||||||
| Ingresos de explotación | $ | 20.8 | $ | 7.9 | NM | $ | 17.6 | $ | 9.8 | NM | ||||||||||||
| Margen de explotación | 7.2 | % | 3.1 | % | 2.1 | % | 1.3 | % | ||||||||||||||
| Ingresos netos | $ | 20.3 | $ | 7.5 | 171 | % | $ | 27.1 | $ | 17.8 | 52 | % | ||||||||||
| Beneficios por acción diluida | $ | 0.47 | $ | 0.18 | 161 | % | $ | 0.63 | $ | 0.42 | 50 | % | ||||||||||
| Medidas no ajustadas a los PCGA* | ||||||||||||||||||||||
| Margen bruto ajustado | 41.0 | % | 39.8 | % | 39.9 | % | 39.2 | % | ||||||||||||||
| EBITDA ajustado | $ | 51.5 | $ | 37.0 | 39 | % | $ | 135.2 | $ | 101.2 | 34 | % | ||||||||||
| Beneficio ajustado por acción diluida | $ | 0.61 | $ | 0.35 | 74 | % | $ | 1.49 | $ | 0.96 | 55 | % | ||||||||||
*El margen bruto ajustado, el EBITDA ajustado y el beneficio por acción diluido ajustado incluyen ajustes no conformes con los PCGA. En este comunicado de resultados se incluye una conciliación entre las métricas conformes con los PCGA y las no conformes con los PCGA.
NM - no significativo.
Management Comments
“We delivered our fourth consecutive quarter of double-digit year-over-year revenue growth, with revenue above the midpoint of our guidance,” said Dr. Mark Gitin, Chief Executive Officer of IPG Photonics. “Our performance reflects the strength of our technology, disciplined execution, and continued progress in expanding our presence in attractive, higher-growth markets. Strong demand for our differentiated welding and additive manufacturing solutions drove growth in Industrial Solutions while disciplined execution of our key strategic initiatives across defense and semiconductor markets led to strong growth in Advanced Solutions. Additionally, I anticipate that our acquisition of Lumibird Medical, which is expected to close in the fourth quarter, will further strengthen our reach, accelerate growth across medical markets, and increase revenue in Advanced Solutions.”
Aspectos financieros destacados
| Tres meses terminados el 30 de septiembre, | Nueve meses finalizados el 30 de septiembre, | ||||||||||||||||
| 2026 | 2025 | Cambia | 2026 | 2025 | Cambia | ||||||||||||
| Ventas por aplicación | |||||||||||||||||
| Soluciones industriales | $ | 239,548 | $ | 214,697 | 12 | % | $ | 704,181 | $ | 607,593 | 16 | % | |||||
| Soluciones avanzadas | 47,952 | 36,095 | 33 | % | 127,396 | 121,713 | 5 | % | |||||||||
| Total | $ | 287,500 | $ | 250,792 | 15 | % | $ | 831,577 | $ | 729,306 | 14 | % | |||||
Third quarter revenue of $288 million increased 15% year over year, driven by 12% growth in Industrial Solutions and 33% growth in Advanced Solutions. Changes in foreign exchange rates increased revenue by approximately 1%. Industrial Solutions sales, accounting for 83% of total revenue, were driven by strong performance in welding and additive manufacturing applications. Advanced Solutions sales improved, driven by higher sales in semiconductor and defense applications. Emerging growth products accounted for 52% of total revenue, down from 58% in the prior quarter due to product mix. By region, sales increased 14% in Asia and 33% in North America and decreased 1% in Europe on a year-over-year basis.
GAAP gross margin of 40.7% and adjusted gross margin of 41.0% increased year over year, driven by lower product costs and $5.0 million in net tariff refunds recorded in the period, partially offset by lower fixed cost absorption. Net income was $20 million, or $0.47 per diluted share, and adjusted EBITDA was $52 million and adjusted earnings per diluted share (EPS) was $0.61 in the third quarter. During the third quarter, IPG generated $46 million in cash flow from operations and spent $17 million on capital expenditures.
Perspectivas de negocio y previsiones financieras
“Our third quarter book-to-bill was approximately one as we continued to see improved industrial demand and executed on our strategic growth initiatives, driving adoption for our differentiated laser and photonics solutions that deliver measurable value to customers. As we move forward, we remain focused on driving profitable growth through innovation, technology differentiation, and operational excellence across our portfolio,” concluded Dr. Gitin.
For the fourth quarter of 2026, IPG expects revenue of $265 million to $295 million, adjusted gross margin between 37.0% and 40.0% and adjusted operating expenses of $91 million to $94 million. IPG anticipates delivering adjusted earnings per diluted share in the range of $0.30 to $0.60 and adjusted EBITDA in the range of $33 million to $50 million. The guidance assumes no contribution from the acquisition of Lumibird Medical.
As discussed in more detail in the "Safe Harbor" passage of this news release, actual results may differ from this guidance due to various factors including, but not limited to, trade policy changes and trade restrictions, product demand, order cancellations and delays, competition, tariffs and retaliatory tariffs, currency fluctuations and general economic conditions. The current uncertainty related to the trade environment and tariff policies increases the risks to the outlook that we have provided. This guidance is based upon current market conditions and expectations and is subject to the risks outlined in the Company's reports filed with the SEC and assumes exchange rates relative to the U.S. dollar of euro 0.88, Japanese yen 157 and Chinese yuan 6.74, respectively.
Información financiera complementaria
Additional supplemental financial information is provided in the unaudited Financial Data Workbook and Third Quarter 2026 Earnings Call Presentation available on the investor relations section of the Company's website at investor.ipgphotonics.com.
Recordatorio de conferencia telefónica
The Company will hold a conference call today, November 3, 2026 at 10:00 am ET. To access the call, please dial 877-407-6184 in the US or 201-389-0877 internationally. A live webcast of the call will also be available and archived on the investor relations section of the Company's website at investor.ipgphotonics.com.
Póngase en contacto con
Eugene Fedotoff
Director Senior de Relaciones con Inversores
Corporación IPG Photonics
508-597-4713
efedotoff@ipgphotonics.com
Acerca de IPG Photonics Corporation
Innovation is at the heart of IPG Photonics. As a global leader in laser technology, we apply light to transform the world. From manufacturing to medical and beyond, our breakthrough laser solutions power our customers’ success and expand what's possible. Discover more at www.ipgphotonics.com.
Safe Harbor Statement
Information and statements provided by IPG and its employees, including statements in this press release, that relate to future plans, events or performance are forward-looking statements. These statements involve risks and uncertainties. Any statements in this press release that are not statements of historical fact are forward-looking statements, including those statements related to strength of our technology, disciplined execution, and continued progress in expanding our presence in attractive, higher-growth markets, the expected timing of the closing of our acquisition of Lumibird Medical and the expectation that the acquisition will increase revenue in Advanced Solutions and strengthen our reach and accelerate growth across medical markets, strategic growth initiatives, driving adoption for our differentiated laser and photonics solutions that deliver measurable value to customers, driving profitable growth through innovation, technology differentiation, and operational excellence across our portfolio, revenue, adjusted gross margin and adjusted operating expenses outlook, adjusted earnings per diluted share and adjusted EBITDA guidance, including the expected impact of tariffs, and the impact of the U.S. dollar on our guidance for the fourth quarter of 2026. Factors that could cause actual results to differ materially include risks and uncertainties, including risks associated with the strength or weakness of business conditions in industries and geographic markets that IPG serves, particularly the effect of downturns in the markets IPG serves; uncertainties and adverse changes in the general economic conditions of markets; inability to manage risks associated with international customers and operations; changes in trade controls and tariff policies; IPG's ability to penetrate new applications for fiber lasers and increase market share; the rate of acceptance and penetration of IPG's products; foreign currency fluctuations; high levels of fixed costs from IPG's vertical integration; the appropriateness of IPG's manufacturing capacity for the level of demand; competitive factors, including declining average selling prices; the effect of acquisitions and investments; inventory write-downs; asset impairment charges; intellectual property infringement claims and litigation; interruption in supply of key components; manufacturing risks; government regulations and trade sanctions; and other risks identified in IPG's SEC filings. Readers are encouraged to refer to the risk factors described in IPG's Annual Report on Form 10-K (filed with the SEC for the fiscal year ended December 31, 2025), IPG's Quarterly Report on Form 10-Q (filed with the SEC for the quarter ended June 30, 2026), and other reports filed with the SEC, as applicable. Actual results, events and performance may differ materially. Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date hereof. IPG undertakes no obligation to update the forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.
| IPG PHOTONICS CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) |
|||||||||||||
| Tres meses terminados el 30 de septiembre, | Nueve meses finalizados el 30 de septiembre, | ||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||
| (En miles, excepto datos por acción) | |||||||||||||
| Ventas netas | $ | 287,500 | $ | 250,792 | $ | 831,577 | $ | 729,306 | |||||
| Coste de las ventas | 170,446 | 151,787 | 502,500 | 446,916 | |||||||||
| Beneficio bruto | 117,054 | 99,005 | 329,077 | 282,390 | |||||||||
| Gastos de explotación: | |||||||||||||
| Ventas y marketing | 23,934 | 23,771 | 72,286 | 73,753 | |||||||||
| Investigación y desarrollo | 31,335 | 30,358 | 95,648 | 88,631 | |||||||||
| Gastos generales y administrativos | 37,502 | 35,092 | 110,139 | 102,782 | |||||||||
| Resolución de litigios | - | - | 13,334 | - | |||||||||
| Provisiones por deterioro | 231 | - | 17,805 | - | |||||||||
| Gastos de reestructuración | - | 425 | - | 425 | |||||||||
| Pérdida por cambio de divisas | 3,275 | 1,504 | 2,293 | 7,013 | |||||||||
| Total gastos de explotación | 96,277 | 91,150 | 311,505 | 272,604 | |||||||||
| Ingresos de explotación | 20,777 | 7,855 | 17,572 | 9,786 | |||||||||
| Otros ingresos, netos: | |||||||||||||
| Ingresos por intereses, netos | 7,688 | 7,283 | 21,720 | 22,728 | |||||||||
| Other (expense) income, net | (50 | ) | 516 | 2,683 | 2,026 | ||||||||
| Total otros ingresos | 7,638 | 7,799 | 24,403 | 24,754 | |||||||||
| Beneficio antes de la provisión para el impuesto sobre sociedades | 28,415 | 15,654 | 41,975 | 34,540 | |||||||||
| Provisión para impuestos sobre la renta | 8,142 | 8,191 | 14,876 | 16,714 | |||||||||
| Ingresos netos | $ | 20,273 | $ | 7,463 | $ | 27,099 | $ | 17,826 | |||||
| Beneficio neto por acción ordinaria: | |||||||||||||
| Básico | $ | 0.48 | $ | 0.18 | $ | 0.64 | $ | 0.42 | |||||
| Diluido | $ | 0.47 | $ | 0.18 | $ | 0.63 | $ | 0.42 | |||||
| Media ponderada de acciones ordinarias en circulación: | |||||||||||||
| Básico | 42,531 | 42,199 | 42,416 | 42,427 | |||||||||
| Diluido | 42,840 | 42,556 | 42,904 | 42,659 | |||||||||
| IPG PHOTONICS CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) |
||||||||
| 30 de septiembre, | 31 de diciembre, | |||||||
| 2026 | 2025 | |||||||
| (In thousands, except share data) | ||||||||
| ACTIVOS | ||||||||
| Activo circulante: | ||||||||
| Efectivo y equivalentes de efectivo | $ | 710,688 | $ | 403,790 | ||||
| Inversiones a corto plazo | 215,304 | 435,538 | ||||||
| Deudores, neto | 191,150 | 181,734 | ||||||
| Inventarios | 337,890 | 313,416 | ||||||
| Impuestos sobre la renta pagados por anticipado | 33,145 | 43,196 | ||||||
| Gastos anticipados y otros activos corrientes | 54,460 | 45,766 | ||||||
| Total activo circulante | 1,542,637 | 1,423,440 | ||||||
| Inversiones a largo plazo | - | 76,533 | ||||||
| Impuestos diferidos, netos | 122,235 | 123,889 | ||||||
| Buena voluntad | 70,281 | 71,735 | ||||||
| Inmovilizado inmaterial, neto | 42,777 | 49,933 | ||||||
| Inmovilizado material, neto | 648,326 | 637,516 | ||||||
| Otros activos | 45,787 | 41,234 | ||||||
| Activo total | $ | 2,472,043 | $ | 2,424,280 | ||||
| PASIVO Y FONDOS PROPIOS | ||||||||
| Pasivo circulante: | ||||||||
| Cuentas por pagar | $ | 48,782 | $ | 39,288 | ||||
| Gastos devengados y otros pasivos corrientes | 204,874 | 184,849 | ||||||
| Impuestos sobre la renta | 3,858 | 9,900 | ||||||
| Total pasivo corriente | 257,514 | 234,037 | ||||||
| Otros pasivos a largo plazo e impuestos diferidos | 59,581 | 62,113 | ||||||
| Total pasivo | 317,095 | 296,150 | ||||||
| Compromisos y contingencias | ||||||||
| Patrimonio neto: | ||||||||
| Common stock, $0.0001 par value, 175,000,000 shares authorized; 57,380,668 and 42,508,140 shares issued and outstanding, respectively, at September 30, 2026; 56,964,939 and 42,127,067 shares issued and outstanding, respectively, at December 31, 2025. |
6 | 6 | ||||||
| Treasury stock, at cost, 14,872,528 and 14,837,872 shares held at September 30, 2026 and December 31, 2025, respectively. |
(1,558,277 | ) | (1,555,629 | ) | ||||
| Capital desembolsado adicional | 1,097,673 | 1,077,172 | ||||||
| Beneficios no distribuidos | 2,672,063 | 2,644,964 | ||||||
| Otras pérdidas globales acumuladas | (56,517 | ) | (38,383 | ) | ||||
| Patrimonio neto total | 2,154,948 | 2,128,130 | ||||||
| Total del pasivo y el patrimonio neto | $ | 2,472,043 | $ | 2,424,280 | ||||
| IPG PHOTONICS CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) |
||||||||
| Nueve meses finalizados el 30 de septiembre, | ||||||||
| 2026 | 2025 | |||||||
| (en miles) | ||||||||
| Flujos de tesorería de las actividades de explotación: | ||||||||
| Ingresos netos | $ | 27,099 | $ | 17,826 | ||||
| Ajustes para conciliar los ingresos netos con la tesorería neta proporcionada por las actividades de explotación: | ||||||||
| Depreciación y amortización | 47,377 | 46,799 | ||||||
| Provisiones por deterioro | 17,805 | - | ||||||
| Provisiones para existencias, garantías y deudas incobrables | 33,594 | 31,766 | ||||||
| Otros | 25,081 | 21,119 | ||||||
| Changes in assets and liabilities that provided (used) cash: | ||||||||
| Cuentas por cobrar y cuentas por pagar | 1,535 | 18,787 | ||||||
| Inventarios | (60,189 | ) | (52,005 | ) | ||||
| Otros | (13,771 | ) | (37,757 | ) | ||||
| Efectivo neto procedente de actividades de explotación | 78,531 | 46,535 | ||||||
| Flujos de tesorería procedentes de actividades de inversión: | ||||||||
| Compras y depósitos de inmovilizado material | (54,437 | ) | (60,907 | ) | ||||
| Ingresos por ventas de inmovilizado material | 2,204 | 605 | ||||||
| Adquisición de inversiones | (360,732 | ) | (866,402 | ) | ||||
| Purchases of equity investment | (8,000 | ) | - | |||||
| Ingresos procedentes del vencimiento de inversiones | 663,124 | 633,731 | ||||||
| Depósito recibido del comprador por los activos destinados a la venta | 2,000 | - | ||||||
| Otros | 111 | 69 | ||||||
| Efectivo neto procedente de (utilizado en) actividades de inversión | 244,270 | (292,904 | ) | |||||
| Flujos de tesorería procedentes de actividades de financiación: | ||||||||
| Payments for taxes related to net share settlement of equity awards less proceeds from issuance of common stock under employee stock option and purchase plans |
(11,053 | ) | (4,316 | ) | ||||
| Compra de acciones propias, neta del impuesto especial, a su coste | (2,648 | ) | (46,603 | ) | ||||
| Efectivo neto utilizado en actividades de financiación | (13,701 | ) | (50,919 | ) | ||||
| Efecto de las variaciones en los tipos de cambio sobre el efectivo, los equivalentes de efectivo y el efectivo destinado a la venta | (1,727 | ) | 23,274 | |||||
| Net increase (decrease) in cash, cash equivalents and cash held for sale | 307,373 | (274,014 | ) | |||||
| Efectivo y equivalentes de efectivo - Inicio del periodo | 403,790 | 620,040 | ||||||
| Efectivo, equivalentes de efectivo y efectivo destinado a la venta — Al cierre del ejercicio | $ | 711,163 | $ | 346,026 | ||||
| Información complementaria sobre el flujo de caja: | ||||||||
| Efectivo pagado por intereses | $ | 54 | $ | 136 | ||||
| Importe en efectivo pagado en concepto de impuestos sobre la renta, una vez deducidas las devoluciones | $ | 9,273 | $ | 44,258 | ||||
| IPG PHOTONICS CORPORATION CUADRO COMPLEMENTARIO DE MEDIDAS FINANCIERAS NO INCLUIDAS EN LOS PCGA (NO AUDITADAS) |
||||||||
Uso de información financiera ajustada no conforme a los PCGA
We refer to certain financial measures that are not recognized under United States generally accepted accounting principles (“GAAP”) and are provided as supplemental information to enhance understanding of the Company’s financial performance. Such non-GAAP financial measures should not be considered superior to, as a substitute for or alternative to, and should be considered in conjunction with, the GAAP financial measure presented by the Company. The following information provides the definition of adjusted gross profit, adjusted gross margin, adjusted operating expense and resultant adjusted operating income, EBITDA, adjusted EBITDA, adjusted net income, adjusted net earnings per share (EPS), and adjusted tax rate as presented, which are financial measures that are not calculated or presented in accordance with GAAP, and reconciliation to the most directly comparable financial measures calculated and presented in accordance with GAAP. The Company has provided adjusted gross profit, adjusted gross margin, adjusted operating expense and resultant adjusted operating income, EBITDA, adjusted EBITDA, adjusted net income, adjusted EPS, and an adjusted tax rate as supplemental information and in addition to the financial measures presented by the Company that are calculated and presented in accordance with GAAP.
We define adjusted gross profit as reported gross profit, adjusted for non-recurring, infrequent, or unusual charges, including acquisition and integration charges and amortization of acquisition-related intangibles.
Definimos el margen bruto ajustado como el beneficio bruto ajustado dividido entre los ingresos totales.
We define adjusted operating expense and resultant adjusted operating income as reported operating expenses and resultant operating income, adjusted for non-recurring, infrequent, or unusual charges, including impairment charges, settlement and fees of litigation matters, restructuring charges, acquisition and integration charges, amortization of acquisition-related intangibles, foreign exchange gains/losses and gain/loss on disposal of assets/divestiture.
Definimos el EBITDA como el beneficio neto más los gastos (o ingresos) por intereses, la provisión para el impuesto sobre sociedades, los gastos por depreciación y los gastos por amortización.
We define adjusted EBITDA as EBITDA adjusted for non-recurring, infrequent, or unusual charges, and other adjustments that the Company believes appropriate, including stock-based compensation, restructuring charges, impairment charges, settlement and fees of litigation matters, acquisition and integration charges, foreign exchange gains/losses and gain/loss on disposal of assets/divestiture.
We define adjusted net income as reported net income, adjusted for non-recurring, infrequent, or unusual charges, and other adjustments that the Company believes appropriate, including impairment charges, settlement and fees of litigation matters, restructuring charges, amortization of acquisition-related intangibles, acquisition and integration charges, foreign exchange gains/losses and gain/loss on disposal of assets/divestiture, certain discrete tax items and non-GAAP income tax reconciling adjustments.
Definimos el beneficio por acción ajustado como el beneficio neto ajustado dividido entre el número medio ponderado de acciones diluidas en circulación.
Definimos el tipo impositivo ajustado como el tipo impositivo según los PCGA, ajustado en función de partidas fiscales puntuales y del impacto neto de los ajustes no contemplados en los PCGA.
La dirección considera que estas medidas financieras no ajustadas a los PCGA ofrecen un medio adicional para evaluar el rendimiento operativo en la comparación interanual. En concreto, estas medidas financieras no ajustadas a los PCGA proporcionan a la dirección un medio adicional para comprender y evaluar los resultados operativos y las tendencias de nuestra actividad corriente, al eliminar determinados gastos no monetarios y otras partidas que, en opinión de la dirección, podrían dificultar las comparaciones de nuestra actividad corriente con periodos anteriores, ocultar las tendencias en las operaciones corrientes o reducir la capacidad de la dirección para realizar previsiones útiles.
In addition, management understands that some investors and financial analysts find this information helpful in analyzing our financial and operational performance and comparing this performance to our peers and competitors. However, these non-GAAP financial measures have limitations as an analytical tool and are not intended to be an alternative to financial measures prepared in accordance with GAAP. In addition, it should be noted that these non-GAAP financial measures may be different from non-GAAP measures used by other companies. Management may, however, utilize other measures to illustrate performance in the future. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures. A reconciliation of our non-GAAP financial measures to their most directly comparable GAAP measures has been provided below. These non-GAAP measures exclude (i) amortization of acquisition-related intangibles, (ii) restructuring charges, (iii) acquisition and integration costs, (iv) impairment charges, (v) foreign exchange gains/losses, (vi) interest income, (vii) benefit (provision) from income taxes, (viii) depreciation, (ix) amortization, (x) stock-based compensation, (xi) gain/loss on disposal of assets/divestiture, (xii) settlement and fees of litigation matters, (xiii) certain discrete tax items, and (xiv) non-GAAP income tax reconciling adjustments.
No hemos facilitado una conciliación cuantitativa de los resultados ajustados no conformes con los PCGA (Non-GAAP) sobre el número de acciones diluidas y del EBITDA ajustado con respecto a sus medidas financieras conformes con los PCGA más directamente comparables, ya que no podemos estimar con una certeza razonable el momento o el importe definitivos de determinadas partidas significativas sin un esfuerzo desproporcionado. Esto se debe a la dificultad inherente de prever el momento y/o el importe de diversas partidas que afectarían a las ganancias ajustadas por acción diluida y al EBITDA ajustado. Esto incluye partidas que aún no se han producido, que están fuera del control de la empresa, que no pueden predecirse razonablemente y/o para las que no habría ningún ajuste o diferencia significativa. Por las mismas razones, la empresa no puede abordar la importancia probable de la información no disponible.
Our non-GAAP tax provision for the fiscal third quarter of 2026 is 23%. The difference between our GAAP income tax provision and our non-GAAP income tax provision is presented as non-GAAP income tax reconciling adjustments.
| IPG PHOTONICS CORPORATION SUPPLEMENTAL SCHEDULE OF NON-GAAP MEASURES (UNAUDITED) |
||||||||||||||||
| Conciliación del beneficio bruto con el beneficio bruto ajustado y el margen bruto ajustado | ||||||||||||||||
| Tres meses terminados el 30 de septiembre, | Nueve meses finalizados el 30 de septiembre, | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| (en miles, salvo los porcentajes) | ||||||||||||||||
| Beneficio bruto | $ | 117,054 | $ | 99,005 | $ | 329,077 | $ | 282,390 | ||||||||
| Margen bruto | 40.7 | % | 39.5 | % | 39.6 | % | 38.7 | % | ||||||||
| Amortización de activos intangibles relacionados con adquisiciones | 720 | 851 | 2,360 | 2,928 | ||||||||||||
| Gastos de adquisición e integración | - | - | - | 482 | ||||||||||||
| Beneficio bruto ajustado | $ | 117,774 | $ | 99,856 | $ | 331,437 | $ | 285,800 | ||||||||
| Margen bruto ajustado | 41.0 | % | 39.8 | % | 39.9 | % | 39.2 | % | ||||||||
Reconciliation of Operating Expenses to Adjusted Operating Expenses
| Tres meses terminados el 30 de septiembre, | Nueve meses finalizados el 30 de septiembre, | |||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||
| (en miles) | ||||||||||||
| Operating expenses | $ | 96,277 | $ | 91,150 | $ | 311,505 | $ | 272,604 | ||||
| Less: | ||||||||||||
| Amortización de activos intangibles relacionados con adquisiciones | 1,231 | 1,551 | 3,701 | 4,570 | ||||||||
| Gastos de adquisición e integración | 151 | 246 | 987 | 1,823 | ||||||||
| Provisiones por deterioro | 231 | - | 17,805 | - | ||||||||
| Gastos de reestructuración | 149 | 425 | 500 | 425 | ||||||||
| Resolución y costas de los litigios | - | - | 14,435 | - | ||||||||
| Pérdida por cambio de divisas | 3,275 | 1,504 | 2,293 | 7,013 | ||||||||
| Adjusted operating expenses | $ | 91,240 | $ | 87,424 | $ | 271,784 | $ | 258,773 | ||||
Reconciliation of Operating Income to Adjusted Operating Income
| Tres meses terminados el 30 de septiembre, | Nueve meses finalizados el 30 de septiembre, | |||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||
| (en miles) | ||||||||||||
| Ingresos de explotación | $ | 20,777 | $ | 7,855 | $ | 17,572 | $ | 9,786 | ||||
| Amortización de activos intangibles relacionados con adquisiciones | 1,951 | 2,402 | 6,061 | 7,498 | ||||||||
| Gastos de adquisición e integración | 151 | 246 | 987 | 2,305 | ||||||||
| Provisiones por deterioro | 231 | - | 17,805 | - | ||||||||
| Gastos de reestructuración | 149 | 425 | 500 | 425 | ||||||||
| Resolución y costas de los litigios | - | - | 14,435 | - | ||||||||
| Pérdida por cambio de divisas | 3,275 | 1,504 | 2,293 | 7,013 | ||||||||
| Resultado operativo ajustado | $ | 26,534 | $ | 12,432 | $ | 59,653 | $ | 27,027 | ||||
Conciliación entre el resultado neto y el EBITDA ajustado
| Tres meses terminados el 30 de septiembre, | Nueve meses finalizados el 30 de septiembre, | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| (en miles) | ||||||||||||||||
| Ingresos netos | $ | 20,273 | $ | 7,463 | $ | 27,099 | $ | 17,826 | ||||||||
| Ingresos por intereses, netos | (7,688 | ) | (7,283 | ) | (21,720 | ) | (22,728 | ) | ||||||||
| Provisión para impuestos sobre la renta | 8,142 | 8,191 | 14,876 | 16,714 | ||||||||||||
| Amortización | 12,986 | 12,392 | 38,447 | 36,120 | ||||||||||||
| Amortización | 2,976 | 3,240 | 8,930 | 10,679 | ||||||||||||
| EBITDA | $ | 36,689 | $ | 24,003 | $ | 67,632 | $ | 58,611 | ||||||||
| Provisiones por deterioro | 231 | - | 17,805 | - | ||||||||||||
| Remuneración basada en acciones | 11,022 | 10,780 | 31,597 | 32,834 | ||||||||||||
| Gastos de reestructuración | 149 | 425 | 500 | 425 | ||||||||||||
| Gastos de adquisición e integración | 151 | 246 | 987 | 2,305 | ||||||||||||
| Resolución y costas de los litigios | - | - | 14,435 | - | ||||||||||||
| Pérdida por cambio de divisas | 3,275 | 1,504 | 2,293 | 7,013 | ||||||||||||
| EBITDA ajustado | $ | 51,517 | $ | 36,958 | $ | 135,249 | $ | 101,188 | ||||||||
Conciliación entre los resultados netos según los PCGA y los resultados netos no ajustados a los PCGA, y entre los resultados netos por acción según los PCGA y los resultados netos por acción no ajustados a los PCGA, diluidos
| Tres meses terminados el 30 de septiembre, | Nueve meses finalizados el 30 de septiembre, | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| (en miles, salvo los datos por acción) | ||||||||||||||||
| Ingresos netos | $ | 20,273 | $ | 7,463 | $ | 27,099 | $ | 17,826 | ||||||||
| Provisiones por deterioro | 231 | - | 17,805 | - | ||||||||||||
| Amortización de activos intangibles relacionados con adquisiciones | 1,951 | 2,402 | 6,061 | 7,498 | ||||||||||||
| Gastos de reestructuración | 149 | 425 | 500 | 425 | ||||||||||||
| Gastos de adquisición e integración | 151 | 246 | 987 | 2,305 | ||||||||||||
| Resolución y costas de los litigios | - | - | 14,435 | - | ||||||||||||
| Pérdida por cambio de divisas | 3,275 | 1,504 | 2,293 | 7,013 | ||||||||||||
| Determinadas partidas fiscales específicas | 949 | 3,414 | 84 | 8,303 | ||||||||||||
| Repercusiones fiscales de los ajustes no conformes con los PCGA | (711 | ) | (613 | ) | (5,337 | ) | (2,471 | ) | ||||||||
| Beneficio neto ajustado | $ | 26,268 | $ | 14,841 | $ | 63,927 | $ | 40,899 | ||||||||
| Beneficio neto ajustado por acción diluida | $ | 0.61 | $ | 0.35 | $ | 1.49 | $ | 0.96 | ||||||||
| Promedio ponderado de acciones en circulación diluidas | 42,840 | 42,556 | 42,904 | 42,659 | ||||||||||||
Conciliación entre la tasa impositiva efectiva según los PCGA y la tasa impositiva efectiva no sujeta a los PCGA
| Tres meses terminados el 30 de septiembre, | Nueve meses finalizados el 30 de septiembre, | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| Tipo impositivo | 29 | % | 52 | % | 35 | % | 48 | % | ||||||||
| Partidas fiscales específicas | (3 | ) | % | (22 | ) | % | - | % | (24 | ) | % | |||||
| Impacto neto de los ajustes no conformes con los PCGA | (3 | ) | % | (3 | ) | % | (11 | ) | % | (3 | ) | % | ||||
| Tipo impositivo ajustado | 23 | % | 27 | % | 24 | % | 21 | % | ||||||||
